Bod Australia’s CBD and hemp oil preparation has achieved ‘Generally Recognised as Safe (GRAS) status in specified food products in accordance with the US Food and Drug Administration (FDA) safety guidelines.
This opens doors for the company to launch its products into the US market.
The regulatory approval follows nine months of planning and preparation by Bod and a stringent review of its operating, extraction and formulation processes by an independent panel of US-based experts.
Bod will immediately progress the launch of around 10 new products in oil and soft gel capsule formats for the US market under existing brands in collaboration with exclusive global partner and Swisse Wellness parent company, Health and Happiness Group (H&H Group).
Bod and H&H Group will launch products directly to consumers through ecommerce platforms and sell through retailers in the US. H&H Group has an established presence in the US and Bod expects to generate significant revenue from the US launch.
Production of first products is expected to commence in the coming months, which will also coincide with first purchase orders from H&H Group.
Bod CEO Jo Patterson said: “Bod is the first ASX-listed company to secure GRAS approval for its extracts and joins a number of top-tier CBD and hemp focused companies, including Charlotte’s Web, as leaders in delivering innovative and safe products to the US market.”